WIRED's Robbie Gonzalez learned to solve a Rubik's cube from Tyson Mao, one of the co-founders of the World Cube Association. In two weeks, Robbie got his solve time down from 45 minutes with Tyson, ...

With as many problems as we are all faced with in our work and life, it seems as if there is never enough time to solve each one without dealing with some adversity along the way. Problems keep ...

For some people, solving a jigsaw puzzle is a relaxing activity, and their preferred way of winding down at the end of the day. For others, it’s a race to the finish. Sure, it’s fun to spend hours ...

In coaching others, I often discuss problem-solving strategies to help individuals think creatively and consider many options when they are faced with challenging situations. Problem solving 1-2 ...

Whether mild or severe, problems occur in businesses all the time. From declining sales to product quality issues to employee challenges, every business faces a unique set of obstacles. It’s important ...

Legal tech has come a long way, but the bulk of an intellectual property or patent lawyer’s work today is still done with spreadsheets, word processors, and PDFs. A startup out of Delaware, Solve ...

One of the most common (and deadly) mistakes in entrepreneurship is creating a solution before identifying the problem. You might think you have the next big idea, but have you really done the ...

Five steps to ensure that you don’t jump to solutions by Julia Binder and Michael D. Watkins When business leaders confront complex problems, there’s a powerful impulse to dive right into “solving” ...

AlphaProof and AlphaGeometry 2 are steps toward building systems that can reason, which could unlock exciting new capabilities. AI models can easily generate essays and other types of text. However, ...

Meta's work made headlines and raised a possibility once considered pure fantasy: that AI could soon outperform the world's best mathematicians by cracking math's marquee "unsolvable" problems en ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...